Corify Care Validates 4-D Global Cardiac Mapping for Complex Atrial and Ventricular Arrhythmias

Corify Care today announced a clinical milestone with two studies published in Heart Rhythm and Europace, validating its 4-D global cardiac mapping technology for atrial and ventricular arrhythmias in a single beat.

Compared with conventional mapping, which often requires rhythm induction or dependence on pre-procedural imaging, the ACORYS mapping system captures global cardiac electrical activity instantly to provide actionable insights before ablation.

“Time and predictability are the most valuable assets in the EP lab,” said Andreu Climent, PhD, CEO of Corify Care. “These publications prove that we can give physicians the full picture upfront, without delay. This is a fundamental shift from mapping to knowing.”

Transforming VT and AF Ablation Workflows

The NIAVAS study in Heart Rhythm demonstrates that Corify’s technology identifies the ventricular tachycardia substrate while the patient remains in normal sinus rhythm, eliminating the need to induce hemodynamically unstable rhythms. The Europace study validates an imageless approach for select atrial arrhythmias, delivering high-accuracy, full-chamber activation maps without pre-acquired CT or MRI.

“We are eliminating guesswork in complex ablation,” said Jana Reventós, MSc, Clinical Affairs Manager and lead author. “For the first time, clinicians can see arrhythmia circuits instantly—without imaging dependencies or procedural risk—enabling confident, targeted intervention from the outset.”

The clinical impact translates to patient care: “With Corify’s technology, we see the full arrhythmia substrate instantly and continuously, which translates into more targeted ablation, shorter procedures, and less risk for the patient,” said Ivo Roca-Luque, MD, PhD, Head of the Arrhythmia Section, Hospital Clínic de Barcelona.

The ACORYS Mapping System complies with European CE marking and U.S. regulatory requirements, having obtained FDA 510(k) clearance.

Corify Care will present new clinical data from these studies, alongside 12 other scientific presentations, at the Heart Rhythm Society 2026 meeting in Chicago, April 23–26.

Corify Care is a MedTech company redefining cardiac mapping with global, whole-heart visualization. Its technology integrates into existing EP workflows, complementing catheter ablation and enabling clinicians to treat complex arrhythmias with greater confidence and efficiency.